Prevalence of Clostridium spp. and Clostridium difficile in Children with Acute Diarrhea in São Paulo City, Brazil

Memorias do Instituto Oswaldo Cruz

Volumn 98, Issue 4, 2003, Pages 451-454

  Ferreira, Claudia E A ^a   Nakano, Viviane ^a   Durigon, Edison L ^a   Avila Campos, Mario J ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acute diarrhea; Brazil; Clostridium difficile; Diagnosis; S o Paulo; Toxins

Indexed keywords

AMIKACIN; AMOXICILLIN; ANTIBIOTIC AGENT; CEFALEXIN; CHLORAMPHENICOL; ERYTHROMYCIN; OXACILLIN; PENICILLIN G; TRIMETHOPRIM; SHIGA TOXIN;

ACUTE DIARRHEA; ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; BRAZIL; CLOSTRIDIUM; CLOSTRIDIUM DIFFICILE; CYTOTOXICITY; FECES ANALYSIS; FEMALE; GENOTYPE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PREVALENCE; STRAIN DIFFERENCE; TOXICITY; VERO CELL; ACUTE DISEASE; ANIMAL; BACTERIAL INFECTION; CASE CONTROL STUDY; CLASSIFICATION; DIARRHEA; FECES; GENETICS; INFANT; ISOLATION AND PURIFICATION; MICROBIOLOGY; NEWBORN;

ANIMALIA; BACTERIA (MICROORGANISMS); CLOSTRIDIA; CLOSTRIDIUM; CLOSTRIDIUM DIFFICILE;

ACUTE DISEASE; ANIMALS; BRAZIL; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; CLOSTRIDIUM; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DIARRHEA; FECES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PREVALENCE; SHIGA TOXINS;

EID: 0142245379     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02762003000400003     Document Type: Article

References (28)

1. Banno Y, Kobayashi T, Kono H, Watanabe K, Ueno K, Nozowa T 1984. Biochemical characterization and biological actions of two toxins (D-1 and D-2) from Clostridium difficile. Rev Infect Dis 6: S11-S20.
2. Bartlett JG 1984. Treatment of antibiotic-associated pseudomembranous colitis. Rev Infect Dis 6: S235-S241.
3. Bressane MA, Durigon, LE, Avila-Campos MJ 2001. Prevalence of the Bacteroides fragilis group and enterotoxigenic Bacteroides fragilis in immunodeficient children. Anaerobe 7: 277-281.
4. Delost MD 1997. Introduction to Diagnostic Microbiology, Mosby, USA, 280 pp.
5. Falk PG, Hooper LV, Midtvedt T, Gordon JI 1998. Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microb Mol Biol Rev 62: 1157-1170.
6. Freeman J, Wilcox MH 1999. Antibiotics and Clostridium difficile. Microb Infect 1: 377-384.
7. Garcia LB, Uzeda, M 1988. Ocorrência de Clostridium difficile nas fezes de crianças do Rio de Janeiro, RJ. Rev Inst Med Trop São Paulo 30: 419-423.
8. George WL, Sutter VL, Citron D, Finegold SM 1979. Selective and differential medium for isolation of C. difficile. J Clin Microbiol 9: 214-219.
9. Gilligan PH, Walden TP, Kelly WF, Wait KJ, Kraft JA, Willis DH 1993. The use of a commercially available enzyme immunoassay for the detection of Clostridium difficile toxin A. Arch Pathol Lab Med 117: 507-510.
10. Gulke I, Pfeifer G, Liese J, Fritz M, Hofmann F, Aktories K 2001. Characterization of the enzymatic component of the ADP-ribosyltransferase toxin CDTa from Clostridium difficile. Infect Immun 69: 6004-6011.
11. Holdeman LV, Moore WEC 1977. Anaerobe Laboratory Manual, 4th ed., Anaerobe Laboratory, Virginia Polytechnic Institute and State University, Blacksburg, 200 pp.
12. Karasawa T, Nojiri T, Hayashi Y, Maegawa T, Yamakawa K, Wang XM 1999. Laboratory diagnosis of toxigenic Clostridium difficile by polymerase chain reaction: presence of toxin genes and their stable expression in toxigenic isolates from Japanese individuals. J Gastrol 34: 41-45.
13. Karlsson S, Lindberg A, Norin E, Burman LG, Akerlund T 2000. Toxins, butyric acid, and other short-chain fatty acids are coordinately expressed and down-regulated by cysteine in Clostridium difficile. Infect Immun 68: 5881-5888.
14. Kalo H, Kato N, Watanabe K, Yamamoto T, Suzuki K, Ishigo S 2001. Analysis of Clostridium difficile isolates from nosocomial outbreaks at three hospitals in diverse areas of Japan. J Clin Microbiol 39: 1391-1395.
15. Knoop FC, Owens M, Crocker IC 1993. Clostridium difficile: clinical disease and diagnosis. Clin Microbiol Rev 6: 251-265.
16. Lee K, Yong D, Yum J, Sohn YS, Chong Y 2000. Modification of cycloserine cefoxitin fructose agar to suppress growth of yeasts from stool specimens. Anaerobe 6: 269-271.
17. Lerm M, Schmidt G, Aktories K 2000. Bacterial protein toxins targeting Rho GTPases. FEMS Microb Lett 188: 1-6.
18. Lyerly DM, Saum KE, MacDonald DK, Wilkins TD 1985. Effects of Clostridium difficile toxins given intra-gastrically to animals. Infect Immun 47: 349-352.
19. McMillin DE, Muldrow LL, Leggette SJ 1992. Simultaneous detection of toxin A and toxin B genetic determinants of Clostridium difficile using the multiplex-polymerase chain reaction. Can J Microbiol 38: 81-83.
20. McVay CS, Rolfe RD 2000. In vitro and in vivo activities of nitrazoxanide against Clostridium difficile. Antimicrob Agents Chemother 44: 2254-2258.
21. Murray PR, Baron EJ, Pfaller MA, Tenover FC, Youlken RH 1995. Manual of Clinical Microbiology, 6th ed., ASM Press, Washington, 583 pp.
22. Niyogi SK, Bhattacharya SK, Dutta P, Naik TN, Prakash S, Sen D, Saha RM, Datta D, Nair GB, Mitra U, Bhattacharya M, Rasaily R, Pal C 1991. Prevalence of Clostridium difficile in hospitalized patients with acute diarrhoea in Calcuta. J Diarrhoeal Dis Res 9: 16-19.
23. Ooi W, Levine HG, LaMont JT, Clark RA 1984. Inactivation of Clostridium difficile cytotoxin by the neutrophil myeloperoxidase system. J Infect Dis 149: 215-219.
24. Peterson LR, Kelly PJ, Nordbrock HA 1996. Role of culture and toxin detection in laboratory testing for diagnosis of Clostridium difficile-associated diarrhea. Eur J Clin Microbiol Infect Immun 15: 330-336.
25. Rocha MFG, Sidrin JJC, Lima AAM 1999. O Clostridium difficile como agente indutor de diarréia inflamatória. Rev Soc Bras Med Trop 32: 47-52.
26. Soyletir G, Eskiturk A, Kilie G, Kortin V, Tozun N 1996. Clostridium difficile acquisition rate and its role in nosocomial diarrhoea at an university hospital in Turkey. Eur J Epidemiol 12: 392-394.
27. Van der Vorm ER 1999. Gas gangrene in an immunocompromised girl due to a Clostridium ramosum infection. Clin Infect Dis 28: 923-924
28. Zhang G, Svenungsson B, Karnell A, Weintraub A 1999. Prevalence of enterotoxigenic Bacteroides fragilis in adult with diarrhea and healthy controls. Clin Infect Dis 29: 590-594.